What Disqualifies You From a Liver Transplant? A Hepatologist Explains Absolute vs. Reversible Contraindications
Introduction
"Why was I turned down?" is one of the hardest conversations in transplant hepatology — and one of the most misunderstood. Patients often assume a "no" is final. In most cases, it isn't. It's a "not yet," tied to a specific, often reversible reason.
Understanding the real categories — permanent vs. temporary, medical vs. donor-related — changes how patients respond to a difficult evaluation outcome.
The two categories that matter
Absolute contraindications — conditions where transplant surgery itself would very likely do more harm than the disease being treated, regardless of timing.
Relative / reversible contraindications — conditions that currently make transplant unsafe or premature, but that can potentially be treated, stabilized, or resolved before reassessment.
Most patients I see who are initially declined fall into the second category. That distinction is worth repeating to every patient who hears "no" for the first time.
Absolute contraindications
- Active, uncontrolled extrahepatic malignancy (cancer outside the liver that has spread)
- Severe, irreversible cardiac or pulmonary disease that makes major surgery unsafe
- Ongoing, uncontrolled sepsis
- Advanced HCC with extensive vascular invasion or spread beyond transplant criteria
- Inability to comply with lifelong immunosuppression (severe, unaddressed psychiatric or cognitive impairment without a support structure)
Relative contraindications — the "not yet" category
This is where most real-world evaluations land, and where careful management can change the outcome entirely.
Active alcohol or substance use. I don't apply a fixed abstinence period as a hard rule — this is genuinely case-by-case. What I weigh: whether this is a first episode or a recurrent pattern of alcohol-related hepatitis, the strength of the patient's social and psychological support system, and — critically — insight. A patient who understands why they're here and what a relapse would cost them post-transplant is a different case from one who doesn't, even if the liver numbers look identical. Duration of abstinence expected before listing follows the same case-by-case logic, not a fixed calendar rule.
Active infection. A controlled, treated infection is not an automatic exclusion — carefully selected cases can proceed once infection is under control, rather than waiting for complete resolution in every instance.
Poor nutritional status / sarcopenia. Often addressable with a pre-transplant optimization program rather than disqualifying on its own.
Uncontrolled cardiac risk factors. Frequently manageable with cardiology optimization before reassessment.
Advanced age alone. Age is just a number. I've evaluated physiologically fit patients well beyond the age most people assume is a cutoff — what matters is functional status, not the birth certificate.
Psychosocial instability or lack of support system. Often addressable through counseling and building a support plan, not an automatic exclusion. [INSERT: how Dr. Kalal actually approaches this conversation with patients/families — this is a sensitive, high-trust section and generic phrasing will feel hollow without his real approach.]
Case: recovery without transplant. A young male presented with a first episode of severe alcoholic hepatitis — a Maddrey discriminant function score above 80, meeting criteria for severe disease, and a clinical picture that looked transplant-bound on the surface. A sepsis screen came back negative. With steroid therapy and aggressive nutritional support, he recovered without needing transplantation. This is the case I point to when patients assume a severe presentation automatically means surgery — a first episode, in the right patient, with the right support, can resolve with medical management alone.
Donor-side disqualification (LDLT-specific — often left out of US-written content)
In living donor transplant, the donor can also be found unsuitable, independent of the recipient's status:
- Blood type incompatibility — not automatically disqualifying. ABO-incompatible (ABOI) transplant is an option in selected patient cohorts, with graft/patient survival in the range of 80-85% in appropriately selected cases with desensitization protocols.
- Insufficient graft-to-recipient weight ratio
- Donor medical conditions that make major surgery unsafe for a healthy person
- Evidence of coercion or lack of true informed consent — donor evaluation includes independent psychological assessment specifically to screen for this
Case: ABOI, early transplant in ACLF. A 55-year-old male with acute-on-chronic liver failure was deteriorating rapidly — this was a case where waiting for a matched donor wasn't a realistic option given the trajectory. His wife came forward to donate. She was not a blood-group match, and the transplant proceeded as an ABO-incompatible transplant, within the selected-cohort protocol where outcomes are acceptable with appropriate desensitization and monitoring. Early transplantation in this setting is often the deciding factor between survival and rapid decline.
When a willing donor is found unsuitable, how that's communicated matters as much as the medical decision itself. My approach: thank them explicitly for their generosity, then be direct — a thorough evaluation has determined we cannot safely proceed, because donor safety is the absolute priority in this field, full stop. I make clear this isn't a reflection of their health in general — it means their specific anatomy isn't suited to the extreme demands of donation, which is a narrow, technical finding, not a verdict on them as a person. It's difficult news, but protecting the donor's long-term wellbeing is non-negotiable, and we turn immediately to exploring alternative options for the patient rather than leaving the family at a dead end.
What happens after a "no"
Being declined at one point in time is not a permanent verdict for most relative contraindications. The typical path:
- Identify the specific reversible factor
- Treat or optimize it
- Reassess at an interval matched to the clinical picture
Timelines aren't one-size-fits-all. In the most rapidly progressive ACLF presentations, the decision window can be as tight as 2 to 3 days — there simply isn't time to wait and watch. In other, somewhat less fulminant presentations, that window extends to roughly 5 to 10 days. For decompensated cirrhosis with recurrent episodes, I typically look at a 3 to 6 month window of stability or optimization before reassessing. All of these are guides, not rules — the actual timeline is case-to-case.
FAQ
If I'm declined once, can I be evaluated again? Yes, for most reversible contraindications, once the underlying issue is addressed.
Does a cancer diagnosis always disqualify me? No — selected early-stage HCC patients remain candidates; extent of disease, not the diagnosis alone, determines eligibility.
Can a family member still be a donor if they're not a blood match? [INSERT: does Dr. Kalal's program use ABO-incompatible or paired exchange protocols, or refer out for these? Don't want to imply a capability that isn't offered.]
Final thought
A transplant evaluation isn't a pass/fail exam — it's a snapshot of risk at one point in time. The right question after a "no" isn't "am I disqualified," it's "what specifically needs to change, and how long will that take."
A successful transplant never comes at the cost of the one who gives. Protecting our donors will always be where the line is drawn.
— Dr. Chetan Kalal, Hepatologist & Liver Transplant Specialist
